Ramin Mojtabai, MD, PhD, MPH

  • 11Articles
  • 79.1KReads
  • 2008–2023Active
  • 35Collaborators
  • 533Citations

About

Ramin Mojtabai, MD, PhD, MPH, is affiliated with the Department of Mental Health at Johns Hopkins Bloomberg School of Public Health and the Department of Psychiatry and Behavioral Sciences at Johns Hopkins University School of Medicine. Since 2008, Mojtabai has published extensively on topics including major depressive disorder, mood disorders, child and adolescent psychiatry, neurodevelopmental conditions, panic disorder, and suicide. His work addresses epidemiological trends, treatment patterns, and risk factors related to depression and related psychiatric conditions.

Publications

JCP
Use of Medication With Depressive Symptom Side Effects
Original Research

Use of Medication With Depressive Symptom Side Effects

May 24, 2023

MDD patients who used non-psychiatric medications with depressive side effects had higher odds of experiencing moderate to severe depressive symptoms.
, , , et al
JCP
Protective Effect of Clozapine on Suicide
Original Research

Protective Effect of Clozapine on Suicide

March 15, 2023

Clozapine, which has shown promise in reducing suicidal behavior in schizophrenia, also appears to lower the odds of suicide death in the general population.
, , , et al
JCP
Original Research

Remission and Treatment Augmentation of Depression

November 2, 2021

Closer monitoring of symptoms through measurement-based care and setting symptom remission as a goal can help improve outcomes for adults with depression.
, , , et al
JCP
Original Research

Trends in Receipt of Mental Health Treatments Among US Adults

October 26, 2016

Since 2008, significant changes in federal policies have been designed to increase access to mental health treatment. Have these changes been effective in influencing treatment-seeking patterns? Han and colleagues...
, , , et al
JCP
Original Research

Prescriptions, Nonmedical Use, and Emergency Department Visits Involving Prescription Stimulants

March 23, 2016

This study points out a dangerous trend—more and more young adults are abusing stimulant medications used to treat ADHD. Is this connected to an increase in prescriptions? Are there...
, , , et al
JCP
Original Research

Antidepressant Use and Lifetime History of Mental Disorders in a Community Sample: Results From the Baltimore Epidemiologic Catchment Area Study

August 5, 2014

, , , et al
JCP
Original Research

National Trends in Long-Term Use of Antidepressant Medications: Results From the US National Health and Nutrition Examination Survey

December 10, 2013

,
JCP
Original Research

A Longitudinal Investigation of the Role of Self-Medication in the Development of Comorbid Mood and Drug Use Disorders: Findings From the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC)

May 15, 2012

, , , et al
JCP
Original Research

Panic as an Independent Risk Factor for Suicide Attempt in Depressive Illness: Findings From the National Epidemiological Survey on Alcohol and Related Conditions (NESARC)

March 22, 2011

, , , et al
JCP
Original Research

Antidepressant Use in the Absence of Common Mental Disorders in the General Population

January 25, 2011

, , , et al
JCP
Original Research

National Patterns in Antidepressant Treatment by Psychiatrists and General Medical Providers: Results From the National Comorbidity Survey Replication

July 31, 2008

,

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe